• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

The Edinburgh Worldwide Investment Trust plc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Baillie Gifford & Co Limited.
Fund Summary The Trust aims for capital growth from a global portfolio of immature entrepreneurial companies, typically with a market capitalisation of less than $5bn at time of initial investment, which are believed to offer long term growth potential.
SEDOL code BHSRZC8
ISIN GB00BHSRZC82
Fund code EWILM
Managers Douglas Brodie, Svetlana Viteva, Luke Ward
Manager Tenure 5 years
Morningstar Category Global Small-Cap Equity
Fund Size Currently unavailable
Fund Type ETF / IT
Management Style Active
Total Expense Ratio (TER) 0.81%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.8422
Buy Price £1.8619
Price Date 14th November 2019
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 28th January 2019
Fund Status OPEN
Douglas graduated BSc in Molecular Biology & Biochemistry from Durham University in 1997 and with a DPhil in Molecular Immunology from the University of Oxford in 2001. He joined Baillie Gifford in 2001 and is Head of the Global Discovery Team. Douglas became a Partner in 2015 is a CFA Charterholder.

3-year Mean Monthly Return: 1.850%

Annual Returns 2018 2017 2016 2015 2014
Fund Performance -6.31% +50.61% +31.98% +14.82% +12.61%
Benchmark Performance
(Global Small-Cap Equity)
-1.17% +10.03% +16.63% +28.62% +4.98%
Time Period Cumulative Benchmark Performance
(Global Small-Cap Equity)
Fund Compared to Benchmark
1 day -0.11% +17.47% -17.57%
1 week 1.86% +3.48% -1.62%
1 month 6.29% -0.46% +6.75%
3 months -4.33% +5.75% -10.07%
6 months 4.44% +9.29% -4.85%
1 year 12.47% +8.45% +4.02%
3 years 24.99% +10.80% +14.19%
5 years 19.48% +10.78% +8.69%
10 years Currently unavailable Currently unavailable Currently unavailable
YTD 25.88% +0.49% +25.39%
Since inception 15.10% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
MarketAxess Holdings Inc USA 5.79%
NovoCure Ltd USA 4.64%
Ocado Group PLC GBR 4.47%
LendingTree Inc USA 4.09%
Alnylam Pharmaceuticals Inc USA 3.46%
Chegg Inc USA 2.99%
Exact Sciences Corp USA 2.39%
Zillow Group Inc C USA 2.17%
PureTech Health PLC USA 2.17%
Temenos AG CHE 2.00%
Dividend Date Per share amount Reinvestment Price
8th January 2015 0.0030 £0.8023
18th June 2014 0.0010 £0.7980
8th January 2014 0.0030 £0.8218
19th June 2013 0.0010 £0.6540
9th January 2013 0.0030 £0.6130
20th June 2012 0.0010 £0.5580